Gene expression profiles in skeletal muscle after gene electrotransfer.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 1925113)

Published in BMC Mol Biol on June 29, 2007

Authors

Pernille Hojman1, John R Zibert, Hanne Gissel, Jens Eriksen, Julie Gehl

Author Affiliations

1: Laboratory of the Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark. pehm@heh.regionh.dk <pehm@heh.regionh.dk>

Articles cited by this

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19

Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A (2001) 68.44

Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39

High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31

Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem (2000) 3.29

Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand (2003) 2.75

Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther (1999) 2.17

Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev (2003) 2.08

Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg (1999) 1.78

Using ANOVA to analyze microarray data. Biotechniques (2004) 1.77

Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci U S A (1999) 1.38

Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther (2002) 1.34

Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol Ther (2005) 1.30

Reversible large-scale deformations in the membranes of electrically-treated cells: electroinduced bleb formation. Biochim Biophys Acta (1990) 1.24

Electric pulse-mediated gene delivery to various animal tissues. Adv Genet (2005) 1.21

K(+)-induced inhibition of contractile force in rat skeletal muscle: role of active Na(+)-K+ transport. Am J Physiol (1991) 1.17

Autoimmune anemia in macaques following erythropoietin gene therapy. Blood (2004) 1.16

Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J Gene Med (2001) 1.16

Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol Ther (2005) 1.10

Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther (2001) 1.09

Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta (2000) 1.08

DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. J Control Release (2005) 1.08

Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther (2005) 1.03

Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther (2001) 1.00

Cyclic stretch-induced reorganization of the cytoskeleton and its role in enhanced gene transfer. Gene Ther (2006) 0.97

Electric field-induced functional reductions in the K+ channels mainly resulted from supramembrane potential-mediated electroconformational changes. Biophys J (1998) 0.97

Supra-physiological membrane potential induced conformational changes in K+ channel conducting system of skeletal muscle fibers. Bioelectrochemistry (2004) 0.93

In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med (2004) 0.93

Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther (2000) 0.92

Manipulation of cell cytoskeleton affects the lifetime of cell membrane electropermeabilization. Ann N Y Acad Sci (1994) 0.92

A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. BMC Mol Biol (2002) 0.90

High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther (2000) 0.90

In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int J Mol Med (2001) 0.87

Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN alpha on visible B16 mouse melanomas. Technol Cancer Res Treat (2002) 0.87

Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure. Am J Nephrol (2003) 0.87

Delivery of electric pulses for DNA electrotransfer to mouse muscle does not induce the expression of stress related genes. Cell Biol Toxicol (2004) 0.86

Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA. Exp Hematol (2001) 0.83

Kinetic of transgene expression after electrotransfer into skeletal muscle: importance of promoter origin/strength. Biochim Biophys Acta (2005) 0.82

Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Ther (2001) 0.82

Efficient and ligand-dependent regulated erythropoietin production by naked dna injection and in vivo electroporation. Am J Kidney Dis (2001) 0.81

betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles. Blood (2001) 0.81

Evidence of electroconformational changes in membrane proteins: field-induced reductions in intra membrane nonlinear charge movement currents. Bioelectrochemistry (2004) 0.77

Articles by these authors

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood (2011) 2.96

Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev (2003) 2.08

Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles. PLoS One (2009) 1.44

Management of cutaneous metastases using electrochemotherapy. Acta Oncol (2011) 1.32

Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res (2011) 1.27

Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab (2008) 1.24

Electric pulse-mediated gene delivery to various animal tissues. Adv Genet (2005) 1.21

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer (2006) 1.15

Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing. BMC Med Genomics (2009) 1.10

Physiological effects of high- and low-voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther (2008) 1.08

Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol (2012) 1.06

Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. Bioelectrochemistry (2011) 1.06

High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS (2011) 1.04

Gene electrotransfer to skin; review of existing literature and clinical perspectives. Curr Gene Ther (2010) 1.03

Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells. J Drugs Dermatol (2012) 1.03

Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res (2012) 1.00

MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells. Mol Pharm (2011) 0.99

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration. Semin Cancer Biol (2003) 0.99

Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy. Radiol Oncol (2012) 0.99

Direct isolation of poly(A)+ RNA from 4 M guanidine thiocyanate-lysed cell extracts using locked nucleic acid-oligo(T) capture. Nucleic Acids Res (2004) 0.98

Effects of running distance and training on Ca2+ content and damage in human muscle. Med Sci Sports Exerc (2004) 0.94

Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Hum Gene Ther Clin Dev (2013) 0.92

What you always needed to know about electroporation based DNA vaccines. Hum Vaccin Immunother (2012) 0.92

Angiotensin converting enzyme inhibitors for cancer treatment? Acta Oncol (2004) 0.90

Tet-On induction with doxycycline after gene transfer in mice: sweetening of drinking water is not a good idea. Anim Biotechnol (2007) 0.90

Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma. Melanoma Res (2012) 0.89

Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Cell Oncol (Dordr) (2014) 0.89

Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy. Radiol Oncol (2013) 0.89

Effects of electrical stimulation and insulin on Na+-K+-ATPase ([3H]ouabain binding) in rat skeletal muscle. J Physiol (2003) 0.88

Electroporation enhances mitomycin C cytotoxicity on T24 bladder cancer cell line: a potential improvement of intravesical chemotherapy in bladder cancer. Bioelectrochemistry (2012) 0.88

Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs (2009) 0.88

Diffusion-weighted MRI for verification of electroporation-based treatments. J Membr Biol (2011) 0.88

Gene expression profiling in chemoresistant variants of three cell lines of different origin. Anticancer Res (2005) 0.87

Development of a metastatic fluorescent Lewis Lung carcinoma mouse model: identification of mRNAs and microRNAs involved in tumor invasion. Gene (2013) 0.86

Persistence of survivin specific T cells for seven years in a melanoma patient during complete remission. Cancer Biol Ther (2006) 0.84

Efficacy of transgene expression in porcine skin as a function of electrode choice. Bioelectrochemistry (2011) 0.83

Efficiency of cellular delivery of antisense peptide nucleic acid by electroporation depends on charge and electroporation geometry. Oligonucleotides (2011) 0.83

Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncol (2015) 0.82

A proteomics approach to the identification of biomarkers for psoriasis utilising keratome biopsy. J Proteomics (2013) 0.81

Comparison of microRNA expression using different preservation methods of matched psoriatic skin samples. Exp Dermatol (2012) 0.81

Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis. Exp Dermatol (2015) 0.81

Change in Hemoglobin Levels due to Anesthesia in Mice: An Important Confounder in Studies on Hematopoietic Drugs. Biol Proced Online (2009) 0.80

Excitation-induced Ca2+ influx and muscle damage in the rat: loss of membrane integrity and impaired force recovery. J Physiol (2004) 0.80

Causes of excitation-induced muscle cell damage in isometric contractions: mechanical stress or calcium overload? Am J Physiol Regul Integr Comp Physiol (2007) 0.80

Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil? J Clin Oncol (2005) 0.79

A novel homologous model for gene therapy of dwarfism by non-viral transfer of the mouse growth hormone gene into immunocompetent dwarf mice. Curr Gene Ther (2014) 0.79

Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle. Hum Gene Ther Methods (2013) 0.79

Excitation-induced cell damage and beta2-adrenoceptor agonist stimulated force recovery in rat skeletal muscle. Am J Physiol Regul Integr Comp Physiol (2005) 0.79

Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential. Mol Biotechnol (2008) 0.78

In Vivo Imaging of Far-red Fluorescent Proteins after DNA Electrotransfer to Muscle Tissue. Biol Proced Online (2009) 0.77

Calcium electrotransfer for termination of transgene expression in muscle. Hum Gene Ther (2011) 0.77

Anoxia induces Ca2+ influx and loss of cell membrane integrity in rat extensor digitorum longus muscle. Exp Physiol (2005) 0.76

Detection of electroporation-induced membrane permeabilization states in the brain using diffusion-weighted MRI. Acta Oncol (2015) 0.75

Exploration of two methods for quantitative Mitomycin C measurement in tumor tissue in vitro and in vivo. Biol Proced Online (2013) 0.75

Correction: Dose-Dependent ATP Depletion and Cancer Cell Death following Calcium Electroporation, Relative Effect of Calcium Concentration and Electric Field Strength. PLoS One (2015) 0.75

Calcium influx determines the muscular response to electrotransfer. Am J Physiol Regul Integr Comp Physiol (2011) 0.75

[Exercise has a positive effect on health-related quality of life for people with cancer during active treatment]. Ugeskr Laeger (2013) 0.75

Electroporation-based DNA delivery technology: methods for gene electrotransfer to skin. Methods Mol Biol (2014) 0.75

[Immunotherapy of cancer]. Ugeskr Laeger (2002) 0.75

Efficient poly(A)+ RNA selection using LNA oligo(T) capture. Methods Mol Biol (2011) 0.75

Anticancer drugs and the regulation of Hedgehog genes GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell lines. Anticancer Drugs (2017) 0.75

Antiangiogenic Metargidin Peptide (AMEP) Gene Therapy in Disseminated Melanoma. Methods Mol Biol (2015) 0.75

Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells. Cancer Chemother Pharmacol (2002) 0.75

Vismodegib and surgery combined - effective treatment of locally advanced basal cell carcinoma. Acta Oncol (2016) 0.75

[Electrochemotherapy for treatment of cutaneous metastases]. Ugeskr Laeger (2015) 0.75